Sackler Institute _{for Developmental Psychobiology}

Publications

• Ross CA, MacCumber MW, Glatt CE, & Snyder SH. (1989). Brain phospholipase C isozymes: Differential mRNA localizations by in situ hybridization. Proc Natl Acad Sci, 86:2923-2927.
  
• Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, & Snyder SH. (1991). Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature, 351:714-718.
• Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, & Snyder SH. (1991). Nitric oxide synthase protein and mRNA are discreetly localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron, 7:615-624.
• Lowenstein CL, Bredt DS, Glatt CE, & Snyder SH. (1992). Cloned and Expressed Macrphage Nitric Oxide Synthase contrasts with the brain enzyme. Proc Natl Acad Sci, 89: 6711-6715.
• Steiner JP, Dawson TM, Fotuhi M, Glatt CE, Snowman AM, Cohen N, & Snyder SH. (1992). High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature, 358: 584-587.
• Hwang PM, Glatt CE, Bredt DS, Yellen G, & Snyder SH. (1992). A novel potassium channel with unique localizations in mammalian brain: molecular cloning and characterization. Neuron, 8:473-481.
• Fotuhi M, Sharp AH,Glatt CE, Hwang PM, Von Krosigk M, Snyder SH, & Dawson TM. (1993). Differential localization of phosphoinositide-liked metabotropic glutamate receptor and the inositol 1,4,5-trisphosphate receptor in rat brain. J Neuroscience, 13: 2001-2012.
• Glatt CE & Snyder SH. (1993). Cloning and expression of an adenylyl cyclase localized to the corpus striatum. Nature, 361: 536-538.
• Verma A, Hirsch DJ, Glatt CE, Ronnett GV, & Snyder SH. (1993). Carbon monoxide: A putative neural messenger. Science, 259: 381-384.
• Glatt CE, Snowman AM, Sibley DR, & Snyder SH. (1995). Clozapine: Selective Labeling of Sites Resembling 5HT-6 Serotonin Receptors May Reflect Psychoactive Profile. Molecular Medicine, 1(4): 398-406.
• Glatt CE, DeYoung JA, Delgado S, Service SK, Giacomini KM, Edwards RH, Risch N, & Freimer NB. (2001). Variant Detection in a Large Reference Sample: Protein Altering Variants are Present at Very low Frequency. Nature Genetics, 27(4): 435-438.
• McInnes LA, Service SK, Reus VI, Barnes G, Charlat O, Jawahar S, Lewitzky S, Yang Q, Duong QY, Spesny M, Araya C, Araya X, Gallegos A, Meza L, Molina J, Ramirez R, Mendez R, Silva S, Fournier E, Batki SL, Mathews CA, Neylan T, Glatt CE, Escamilla MA, Luo D, Gajiwala P, Song T, Crook S, Nguyen JB, Roche E, Meyer JM, Leon P, Sandkuijl LA, Freimer NB, & Chen H. (2001). Fine-scale mapping of a locus for severe bipolar mood disorder on chromosome 18p11.3 in the Costa Rican population. Proc Natl Acad Sci, 98:11485-11490.
• Glatt CE & Freimer NB. (2002). Association analysis of candidate genes for neuropsychiatric disease: the perpetual campaign. Trends in Genetics, 18(6):307-12.
• Glatt CE & Reus VI. (2003). Pharmacogenetics of monoamine transporters. Pharmacogenomics 4(5): 583-596.
• Glatt CE, Tampilic M, DeYoung J, & Freimer NB. (2004). Re-Screening Serotonin Receptors for Genetic Variants Identifies Population and Molecular Genetic Complexity. Am J Med Genet, 124B: 92-100.
• Breidenthal SE, White DS, & Glatt CE. Identification of Genetic Variants in the Neuronal Form of Tryptophan Hydroxylase (TPH2). Psychiatric Genetics, 14(2): 69-72, 2004.
• Burman J, Tran CH,Glatt CE, Freimer NB & Edwards, RH. The effect of rare human sequence variants on the function of vesicular monoamine transporter 2. Pharmacogenetics 2004, 14:1Ð8.
• Glatt CE, Tampilic M, Taylor T, Edwards RH, Freimer NB, Tanner C. Structural Variants in the Vesicular Monoamine Transporter do not Contribute to Sporadic Parkinson Disease. Movement Disorders 21(3):426-427 2006
• Glatt CE, Wahner AD, White DJ, Ruiz-Linares A, Ritz B. Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women. Hum Mol Genet. 2006, 15:299-305.
• Glatt CE, Carlson E, Taylor TR, Risch N, Reus VI, Schaefer CA. Response to Zhang et al.: loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron. 2005, 48:704-5.
• Glatt CE, Tampilic M, Carlson E, Taylor T, Edwards,RH, Freimer NB, Tanner CM, and the Parkinson Study Group Structural Variants in the Vesicular Monoamine Transporter do not Contribute to Sporadic Parkinson Disease. Movement Disorders. 2006, 21(3):426-427.